Yes, targeting the TME is a promising strategy. Several approaches are being explored: - Immunotherapy: By reactivating immune cells within the TME, therapies like checkpoint inhibitors can enhance anti-tumor responses. - Anti-Angiogenic Therapy: Drugs that inhibit angiogenesis can starve the tumor of nutrients and oxygen. - Stromal Targeting: Disrupting the supportive role of stromal cells can hinder tumor growth.
